33 results found (page 1 of 3)
https://www.federalregister.gov/documents/2026/04/14/2026-07205/medicare-and-medicaid-prog…

…rules that are currently in effect suggest that making an exception available prevents the FFE from potentially losing issuer participation based on concerns the issuer will ultimately be able to address during or before the plan year, typically resulting in no potential harm to …

https://www.academia.edu/164587317/Juan_Garc%C3%A9s_and_Alexander_Lasch_Mehrsprachige_Arbe…

…e innen Br. Johannes über die gestrige Brother Johannes spoke about yesterday's events. Broer Johannes het oor gister se gebeure gepraat. GN1765_1_584 u. heutige Loos. redete, wurden 3 leib. und heutige Losung redete, wurden 3 leib. and today's motto was spoken, 3 bodies were bor…

https://tools.ietf.org/html/rfc9110

…origin server MUST replace that value with the message origination date. This prevents a future modification date from having an adverse impact on cache validation. An origin server without a clock MUST NOT generate a Last-Modified date for a response unless that date value was a…

https://rfc-editor.org/rfc/rfc9110

…origin server MUST replace that value with the message origination date. This prevents a future modification date from having an adverse impact on cache validation. An origin server without a clock MUST NOT generate a Last-Modified date for a response unless that date value was a…

https://www.ietf.org/rfc/rfc9110.html

…origin server MUST replace that value with the message origination date. This prevents a future modification date from having an adverse impact on cache validation. An origin server without a clock MUST NOT generate a Last-Modified date for a response unless that date value was a…

https://www.federalregister.gov/documents/2025/08/04/2025-14681/medicare-program-hospital-…

… instead interquartile ranges ( 90 FR 18099 ). The applicant summarized adverse events reported in Cauchy et al. (2011) and Crooks et al. (2022), as well as a multicenter retrospective cohort study and the AURLUMYN TM prescribing information. The applicant also referenced the NDA…